.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Citi
Merck
McKesson
Harvard Business School
Teva
AstraZeneca
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson

Generated: September 21, 2017

DrugPatentWatch Database Preview

VENTOLIN Drug Profile

« Back to Dashboard

Which patents cover Ventolin, and what generic Ventolin alternatives are available?

Ventolin is a drug marketed by Glaxosmithkline and is included in seven NDAs. There are fifteen patents protecting this drug.

The generic ingredient in VENTOLIN is albuterol. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albuterol profile page.

Summary for Tradename: VENTOLIN

Patents:0
Applicants:1
NDAs:7
Bulk Api Vendors: see list135
Clinical Trials: see list33
Patent Applications: see list6,729
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VENTOLIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
VENTOLIN
albuterol sulfate
TABLET;ORAL019112-001Jul 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
SOLUTION;INHALATION019269-002Jan 16, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
Glaxosmithkline
VENTOLIN HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VENTOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
VENTOLIN
albuterol sulfate
TABLET;ORAL019112-001Jul 10, 1986► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
SYRUP;ORAL019621-001Jun 10, 1987► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
TABLET;ORAL019112-002Jul 10, 1986► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
TABLET;ORAL019112-002Jul 10, 1986► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol
AEROSOL, METERED;INHALATION018473-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol
AEROSOL, METERED;INHALATION018473-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
TABLET;ORAL019112-001Jul 10, 1986► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
SYRUP;ORAL019621-001Jun 10, 1987► Subscribe► Subscribe
Glaxosmithkline
VENTOLIN
albuterol sulfate
SYRUP;ORAL019621-001Jun 10, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
AstraZeneca
Johnson and Johnson
US Department of Justice
Argus Health
Federal Trade Commission
Julphar
Dow
Fish and Richardson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot